Medical Progress Today / New York Post / Institute’s Trial Lawyers Inc. / Yale Journal / Dallas Morning News / McKinsey and Company / Medtronic / Olin / Investor / The Wall Street Journal / The National Law Journal / Wyeth / PointOfLaw.com / /
Continent
America / /
Country
United States / /
Event
Judicial Event / FDA Phase / /
Facility
Legal Policy Manhattan Institute / Manhattan Institute / University of North Carolina / Chapel Hill / Medical Progress Manhattan Institute / Fordham University / /
IndustryTerm
medical devices / state-based common-law tort system / drug manufacturer / web magazine / product-liability law / potential medical products / medical products / online newspapers / beneficial medical products / manufacturing / increased information on product / biomedical products / respective products / /
MedicalCondition
plaintiff’s tragic injury / medical injuries / unforeseen drug injuries / unforeseen injuries / pain / given illness / injuries / /
MedicalTreatment
open-heart surgery / /
NaturalFeature
Chapel Hill / /
Organization
Manhattan Institute’s Center for Legal Policy / College of the Holy Cross / Manhattan Institute / University of North Carolina / Yale / Center for Legal Policy / United States Court of Appeals / Medical Progress Manhattan Institute for Policy Research Published / Legal Policy Manhattan Institute / Medicare / Congress / U.S. Supreme Court / U.S. Food and Drug Administration / Fordham University / FDA / London School of Economics / /
Person
Henry Waxman / Frank Pallone / James R. Copland / Paul Howard / /
Position
editor / project manager / management consultant / Director / Center / deputy director / Administrative Compensation Executive / director / treating physician / managing editor / assistant / regular speaker / law clerk / member / /
Product
suing drug / /
ProvinceOrState
New Jersey / North Carolina / California / Massachusetts / /
PublishedMedium
The Wall Street Journal / the Yale Journal / The National Law Journal / the New York Post / /
Technology
how 21st-century technologies / Drug Development / /
Project FDA Report James R. Copland Director, Center for Legal Policy Manhattan Institute for Policy Research Paul Howard